Concerns Regarding the Potential Drug Side Effects and Follow-Up Duration in the Study “Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting”: A Reply

Authors

Institutions

Publication Details

Journal
The Journal of Tehran University Heart Center
Published
2025-04-21
DOI
https://doi.org/10.18502/jthc.v19i1.18448
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concerns Regarding the Potential Drug Side Effects and Follow-Up Duration in the Study “Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting”: A Reply

Elnaz Javanshir
The Journal of Tehran University Heart Center
Lipoproteins and Cardiovascular Health
article

Concerns Regarding the Potential Drug Side Effects and Follow-Up Duration in the Study “Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting”: A Reply

Elnaz Javanshir
article en

Abstract

No abstract available for this paper.
The Journal of Tehran University Heart CenterVol. 19(1)
Tabriz University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 86%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Concerns Regarding the Potential Drug Side Effects and Follow-Up Duration in the Study “Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting”: A Reply — Elnaz Javanshir · The Journal of Tehran University Heart Center (2025) | TGRS Research Map | TGRS